Clariane Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Clariane şu anda temettü ödemiyor.

Anahtar bilgiler

Temettü verimi

-48.9%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-48.9%
Gelecekteki Temettü Verimi	20.0%
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	€0.250
Ödeme oranı	0%

Son temettü ve geri alım güncellemeleri

Recent updates

Here's Why It's Unlikely That Clariane SE's (EPA:CLARI) CEO Will See A Pay Rise This Year

Jun 04

Clariane SE (EPA:CLARI) Shares Could Be 33% Below Their Intrinsic Value Estimate

May 22

Market Participants Recognise Clariane SE's (EPA:CLARI) Revenues Pushing Shares 187% Higher

May 22

Clariane (EPA:CLARI) Takes On Some Risk With Its Use Of Debt

Apr 28

Is It Too Late To Consider Buying Clariane SE (EPA:CLARI)?

Dec 06

These 4 Measures Indicate That Clariane (EPA:CLARI) Is Using Debt Extensively

Oct 31

Calculating The Fair Value Of Clariane SE (EPA:CLARI)

Sep 21

What Is Clariane SE's (EPA:CLARI) Share Price Doing?

Jul 29

At €6.98, Is It Time To Put Korian (EPA:KORI) On Your Watch List?

Apr 04

These 4 Measures Indicate That Korian (EPA:KORI) Is Using Debt Extensively

Mar 16

A Look At The Fair Value Of Korian (EPA:KORI)

Jan 16

Should You Think About Buying Korian (EPA:KORI) Now?

Dec 26

Does Korian (EPA:KORI) Have A Healthy Balance Sheet?

Dec 01

Is There Now An Opportunity In Korian (EPA:KORI)?

Sep 26

Is Korian (EPA:KORI) A Risky Investment?

Aug 31

Why Korian (EPA:KORI) Could Be Worth Watching

Jun 14

We Think Korian (EPA:KORI) Is Taking Some Risk With Its Debt

Mar 30

Korian (EPA:KORI) Has A Somewhat Strained Balance Sheet

Dec 24

Korian (EPA:KORI) Seems To Be Using A Lot Of Debt

Sep 25

Why Korian (EPA:KORI) Could Be Worth Watching

Jul 15

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: CLARI şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: CLARI şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Clariane Piyasaya Karşı Temettü Getirisi

CLARI temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (CLARI)	0%
Pazarın Alt %25'i (FR)	2.1%
Pazarın En İyi %25'i (FR)	5.5%
Sektör Ortalaması (Healthcare)	2.2%
Analist tahmini (CLARI) (3 yıla kadar)	20.0%

Önemli Temettü: CLARI şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, CLARI şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: CLARI French piyasası için dikkate değer bir temettü ödemiyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: CLARI herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Clariane Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Clariane Announces Dividend for the Financial Year 2022, Payable on July 13, 2023

Clariane Announces Dividend for the Financial Year 2022, Payable on July 13, 2023

Upcoming dividend of €0.25 per share at 3.3% yield

Upcoming dividend of €0.35 per share

Korian Proposes Dividend

Recent updates

Revenues Tell The Story For Clariane SE (EPA:CLARI) As Its Stock Soars 26%

Clariane SE, Annual General Meeting, May 14, 2025

Clariane SE to Report Fiscal Year 2024 Results on Feb 24, 2025

Clariane Group Announces Management Changes

Here's Why Clariane (EPA:CLARI) Has A Meaningful Debt Burden

Clariane Se Provides Earnings Guidance for the Full Year 2024; Reiterates Earnings Guidance for the Full Year from 2023 to 2026

Clariane SE's (EPA:CLARI) 26% Cheaper Price Remains In Tune With Revenues

New major risk - Shareholder dilution

Now 20% undervalued

Odalys SA acquired Les Essentielles - SARL from Clariane SE (ENXTPA:CLARI).

Price target increased by 82% to €7.90

New minor risk - Shareholder dilution

Clariane SE has filed a Follow-on Equity Offering in the amount of €237.083186 million.

Clariane SE Appoints Sylvia Metayer as Non-Executive Director

Here's Why It's Unlikely That Clariane SE's (EPA:CLARI) CEO Will See A Pay Rise This Year

Clariane SE (EPA:CLARI) Shares Could Be 33% Below Their Intrinsic Value Estimate

Market Participants Recognise Clariane SE's (EPA:CLARI) Revenues Pushing Shares 187% Higher

Clariane (EPA:CLARI) Takes On Some Risk With Its Use Of Debt

Price target decreased by 12% to €3.83

Clariane Confirms Rumor of Disposal of HAD/SSIAD Business in France

Price target decreased by 11% to €4.01

Full year 2023 earnings released

Elevation Healthcare Properties managed by Elevation Advisors signed an agreement to acquire Berkley Care Group Ltd from Clariane SE (ENXTPA:CLARI) for £207 million.

Investor sentiment deteriorates as stock falls 22%

Investor sentiment deteriorates as stock falls 18%

Clariane SE to Report First Half, 2024 Results on Jul 30, 2024

Is It Too Late To Consider Buying Clariane SE (EPA:CLARI)?

Price target decreased by 22% to €6.73

Investor sentiment deteriorates as stock falls 17%

These 4 Measures Indicate That Clariane (EPA:CLARI) Is Using Debt Extensively

New major risk - Share price stability

Investor sentiment deteriorates as stock falls 31%

Clariane SE to Report Fiscal Year 2023 Results on Feb 28, 2024

Now 20% undervalued after recent price drop

Calculating The Fair Value Of Clariane SE (EPA:CLARI)

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

Price target decreased by 11% to €10.44

Consensus EPS estimates fall by 82%

What Is Clariane SE's (EPA:CLARI) Share Price Doing?

First half 2023 earnings released

Clariane Announces Dividend for the Financial Year 2022, Payable on July 13, 2023

Clariane Announces Dividend for the Financial Year 2022, Payable on July 13, 2023

Upcoming dividend of €0.25 per share at 3.3% yield

Consensus EPS estimates increase by 18%

Now 21% undervalued after recent price drop

At €6.98, Is It Time To Put Korian (EPA:KORI) On Your Watch List?

These 4 Measures Indicate That Korian (EPA:KORI) Is Using Debt Extensively

Consensus EPS estimates increase by 20%

Price target decreased by 11% to €20.50

Investor sentiment deteriorates as stock falls 19%

Consensus EPS estimates fall by 50%, revenue upgraded

Price target decreased by 8.2% to €21.63

Full year 2022 earnings released

Price target decreased by 7.4% to €21.94

A Look At The Fair Value Of Korian (EPA:KORI)

Korian (ENXTPA:KORI) acquired Grupo 5 Acción y Gestión Social, S.A. from Corpfin Capital Asesores, S.A., SGEIC and others.

Should You Think About Buying Korian (EPA:KORI) Now?

Korian to Report First Half, 2023 Results on Jul 27, 2023

Does Korian (EPA:KORI) Have A Healthy Balance Sheet?

Consensus forecasts updated

Price target decreased to €24.69

Investor sentiment deteriorated over the past week

Is There Now An Opportunity In Korian (EPA:KORI)?

Is Korian (EPA:KORI) A Risky Investment?

First half 2022 earnings released

Korian Appoints Philippe Lévêque as Director and Chairman of the Ethics, Quality and CSR Committee

Upcoming dividend of €0.35 per share

Why Korian (EPA:KORI) Could Be Worth Watching

Investor sentiment deteriorated over the past week